Alberta Project Explores Use of Synthetic Data as Alternative to Health Data Utilization

Ads

You May Also Like

Aileron Therapeutics Announces Expansion of Scientific Advisory Board

CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), the clinical-stage leader ...

Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer

Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery ...